Interestingly, pancreas cancer was also more frequent in double heterozygotes of a BRCA1 pathogenic variant and BRCA2 c.9976A>T variant, suggesting a potential genetic modifier effect (Table 2, Figure 2). Here, BRCA1 is linked to pancreatic neoplasm.